We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Join TianLong at ADLM 2024 to Explore the Latest Diagnostic Innovations!

By Xi'an Tianlong Science & Technology Co., Ltd
Posted on 19 Jul 2024

Founded in 1997, TianLong Science and Technology Co., Ltd. More...

is a Chinese manufacturer dedicated to genetic testing and molecular diagnostics, providing products and total solutions including nucleic acid extractors (magnetic beads method), PCR thermal cyclers, real-time PCR systems, All-in-one molecular diagnosis systems, and hundreds of compatible extraction kits and detection kits.

With ISO 13485 and ISO 9001 certifications, and over 200 NMPA, CE and FDA registration certificates, Tianlong products have been exported to more than 100 countries and regions worldwide, underscoring the reliability and safety of Tianlong's top-quality products.

We are pleased to invite you to visit our Booth #4822 at the upcoming ADLM 2024 Clinical Lab Expo. We will be showcasing our latest instruments and reagents, covering a wide range of products and solutions in molecular diagnostics, biochemistry, immunology, POCT, and conducting live demonstrations, and sharing valuable information about our innovative solutions.

Mark the calendar, we look forward to meeting you!

l   ADLM 2024 Clinical Lab Expo

l   Date: July 30th - August 1st, 2024

l   Location: McCormick Place, Chicago

l   Booth Number: #4822

For further information or to schedule a meeting, please email us at inquiry@medtl.com.


Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Microscope
dIFine
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.